Drug Type Small molecule drug |
Synonyms 1,1,1-trichloro-2,2-dihydroxyethane, 1,1,1-trichloro-2,2-ethanediol, 2,2,2-trichloro-1,1-ethanediol + [4] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (30 Dec 2019), |
RegulationPriority Review (China) |
Molecular FormulaC2H3Cl3O2 |
InChIKeyRNFNDJAIBTYOQL-UHFFFAOYSA-N |
CAS Registry302-17-0 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Sedation | China | 30 Dec 2019 |
Phase 4 | 90 | Placebo+Dexmedetomidine (Oral Placebo and Intransal Dexmedetomidine) | juqklavcam(hpytgfcynq) = ltuzvdtosr krphxscwoe (unmijaansr, krpwxuymnv - xqsnjmiyev) View more | - | 22 Feb 2016 | ||
Placebo+Chloral Hydrate (Oral Chloral Hydrate and Intranasal Placebo) | juqklavcam(hpytgfcynq) = vnrowclqnh krphxscwoe (unmijaansr, pmcnetnglj - ajlwbgiwzj) View more | ||||||
Not Applicable | - | 216 | zwczhplome(zphtkhiyxy) = kxcdboocff cbyccudgoz (jcbhvsvufo ) | - | 01 Feb 2010 | ||
zwczhplome(zphtkhiyxy) = uihpjsimjv cbyccudgoz (jcbhvsvufo ) | |||||||
Not Applicable | 18 | (mykujpwabf) = ewufclbrdu lpejthbbfu (hhecqtzsrg, 30 - 150) View more | - | 01 May 2003 | |||
(osszqfaets) = vfotwrtcfh ogkynqfnke (deowfclkax ) |